When Does Adrenal Cortical Myelolipoma Require Treatment?

Adrenal cortical myelolipoma is managed according to a structured, evidence-based protocol. The central clinical question is identifying which presentations meet the defined criteria for active intervention versus ongoing monitoring.

Treatment approach (partial) A surgical option is available and is addressed within the protocol — applicable only under specific defined conditions relating to lesion characteristics and the clinical presentation. The complete eligibility criteria, decision pathway, and full algorithm are available in the structured protocol. Dosages, criteria, and full sequencing are accessible via the link below.

Instant Access to Structured Evidence-Based Regimens

References

Adrenalectomy is rarely needed and is usually reserved for very large lesions with substantial symptoms of mass effect, or acute haemorrhage.

However, adrenalectomy in these cases is usually reserved only if symptoms of mass effect or acute haemorrhage is present.

View source ↗